采用临床光子计数高螺距技术降低CT肺动脉造影对比剂剂量
本研究回顾性纳入105例CT肺动脉造影患者,使用新型光子计数探测器CT和高螺距双源扫描,对比剂剂量逐步降低分为35 ml、45 ml和60 ml三组,评估图像质量和肺动脉强化程度;结果显示35 ml组主观图像质量最高,各组肺动脉干平均CT值无显著差异,结论认为使用35 ml对比剂即可获得诊断性CT肺动脉造影。
要点
- 光子计数探测器CT结合高螺距双源扫描可在35 ml碘对比剂下完成诊断性CT肺动脉造影。
- 35 ml组主观图像质量评分4.6,高于45 ml组的4.5和60 ml组的4.1,组1与组3、组2与组3差异显著。
- 各组可评估的段肺动脉数量无显著差异,肺动脉干平均CT值三组间无显著差异(p=0.69)。
核心结论
- 使用光子计数探测器CT行高螺距CT肺动脉造影时,对比剂剂量可显著降低而不降低图像质量,35 ml对比剂即可获得诊断性图像。
研究设计与样本
- 回顾性研究,共纳入105例临床行CT肺动脉造影的患者,使用光子计数探测器CT(Naeotom Alpha,Siemens Healthineers)行团注跟踪和高螺距双源扫描(FLASH模式),对比剂为Accupaque 300(GE Healthcare),按剂量分为35 ml组(n=29)、45 ml组(n=62)和60 ml组(n=14),由4名阅片者独立评估图像质量和段肺动脉可评估性。
关键影像表现/征象
- 主观图像质量评分35 ml组为4.6,45 ml组为4.5,60 ml组为4.1,组1与组3差异显著(p < 0.001),组2与组3差异显著(p = 0.003)。
- 三组可评估的段肺动脉数量分别为18.5、18.7、18.4,组间无显著差异。
- 肺动脉干平均CT值35 ml组为321 ± 92 HU,45 ml组为345 ± 93 HU,60 ml组为347 ± 88 HU,组间无显著差异(p = 0.69)。
临床应用与阅片要点
- 作者结论认为,光子计数探测器CT行高螺距CT肺动脉造影时使用35 ml对比剂即可获得诊断性图像,可在不降低图像质量的前提下显著降低对比剂剂量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the potential to reduce the amount of iodinated contrast media (CM) for computer tomographic pulmonary angiography (CTPA) with a novel photon-counting-detector CT (PCCT).
MATERIALS AND METHODS: Overall, 105 patients referred for CTPA were retrospectively included in this study. CTPA was performed using bolus tracking and high-pitch dual-source scanning (FLASH mode) on a novel PCCT (Naeotom Alpha, Siemens Healthineers). CM (Accupaque 300, GE Healthcare) dose was lowered stepwise following the introduction of the new CT scanner. Thus, patients could be divided into 3 groups as follows: group 1, n = 29, 35 ml of CM; group 2, n = 62, 45 ml of CM and group 3, n = 14, 60 ml of CM. Four readers independently assessed the image quality (Likert-scale 1-5) and adequate assessment of the segmental pulmonary arteries. Additionally, the pulmonary arterial contrast opacification was measured.
RESULTS: The subjective image quality was rated highest in group 1 with 4.6 compared to 4.5 (group 2) and 4.1 (group 3) with a significant difference between groups 1 and 3 (p < 0.001) and between groups 2 and 3 (p = 0.003). In all groups, almost all segmental pulmonary arteries could be assessed adequately without significant differences (18.5 vs. 18.7 vs. 18.4). Mean attenuation in the pulmonary trunk did not differ significantly between groups 321 ± 92 HU versus 345 ± 93 HU versus 347 ± 88 HU (p = 0.69).
CONCLUSION: Significant CM dose reduction is possible without a reduction in image quality. PCCT enables diagnostic CTPA with 35 ml of CM.
引用
- Saeed, Niehoff, Boriesosdick, et al. Minimizing Contrast Media Dose in CT Pulmonary Angiography with Clinical Photon Counting Using High Pitch Technique. Acad Radiol. 2023. PMID: 37393176. doi:10.1016/j.acra.2023.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。